What’s Next For Glaukos After A Large 35% Drop In A Week?
The stock price of Glaukos (NYSE:GKOS), a pharmaceutical company focused on treatment of glaucoma, corneal disorders, and retinal diseases, reached its all-time high of $96 in February this year before a recent sell-off in the stock, which led to a large 50% drop in its price to levels of $48 currently. Much of this fall came in over the last week or so, with GKOS stock falling 35%, after multiple downgrades on the stock, following the concerns about the proposed physician fee schedule established by the Centers for Medicare and Medicaid Services (CMS). [1] The investors fear that the proposed changes by the CMS will significantly impact the amount of reimbursement that the company receives from Medicare for glaucoma surgical procedures using its iStent device, weighing on GKOS stock.
Now, after a a large 34% fall in a week, will GKOS stock continue its downward trajectory over the coming weeks, or is a recovery in the stock imminent? According to the Trefis Machine Learning Engine, which identifies trends in the company’s stock price using ten years of historical data, returns for GKOS stock average just 0.4% in the next one-month (twenty-one trading days) period after experiencing a 35% drop over the previous week (five trading days), implying that the GKOS stock is best avoided for now.
But how would these numbers change if you are interested in holding GKOS stock for a shorter or a longer time period? You can test the answer and many other combinations on the Trefis Machine Learning Engine to test Glaukos stock chances of a rise after a fall. You can test the chance of recovery over different time intervals of a quarter, month, or even just 1 day!
MACHINE LEARNING ENGINE – try it yourself:
IF GKOS stock moved by -5% over five trading days, THEN over the next twenty-one trading days GKOS stock moves an average of 2.4%, with a 58% probability of a positive return over this period.
Some Fun Scenarios, FAQs & Making Sense of Glaukos Stock Movements:
Question 1: Is the average return for Glaukos stock higher after a drop?
Answer: Consider two situations,
Case 1: Glaukos stock drops by -5% or more in a week
Case 2: Glaukos stock rises by 5% or more in a week
Is the average return for Glaukos stock higher over the subsequent month after Case 1 or Case 2?
GKOS stock fares better after Case 1, with an average return of 2.4% over the next month (21 trading days) under Case 1 (where the stock has just suffered a 5% loss over the previous week), versus, an average return of 1% for Case 2.
In comparison, the S&P 500 has an average return of 3.1% over the next 21 trading days under Case 1, and an average return of just 0.5% for Case 2 as detailed in our dashboard that details the average return for the S&P 500 after a fall or rise.
Try the Trefis machine learning engine above to see for yourself how Glaukos stock is likely to behave after any specific gain or loss over a period.
Question 2: Does patience pay?
Answer: If you buy and hold Glaukos stock, the expectation is over time the near-term fluctuations will cancel out, and the long-term positive trend will favor you – at least if the company is otherwise strong.
Overall, according to data and Trefis machine learning engine’s calculations, patience absolutely pays for most stocks!
For GKOS stock, the returns over the next N days after a -5% change over the last 5 trading days is detailed in the table below, along with the returns for the S&P500:
You can try the engine to see what this table looks like for Glaukos after a larger loss over the last week, month, or quarter.
Question 3: What about the average return after a rise if you wait for a while?
Answer: The average return after a rise is understandably lower than after a fall as detailed in the previous question. Interestingly, though, if a stock has gained over the last few days, you would do better to avoid short-term bets for most stocks – although GKOS stock appears to be an exception to this general observation.
It’s pretty powerful to test the trend for yourself for Glaukos stock by changing the inputs in the charts above.
While GKOS stock is best avoided in the near term, 2020 has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for Mettler vs Abbott.
See all Trefis Price Estimates and Download Trefis Data here
What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams
Notes:- Glaukos Press Release, Jul 14, 2021 [↩]